Position in ACHV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$603,035
-$564,601 QoQ
Shares Held
205,114
-12.7% QoQ
Ownership
0.200%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#19
of 81 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Shay Capital LLC holds $20,631,237 across 39 Biotechnology names. ACHV ranks #14 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QNCX |
Quince Therapeutics, Inc.
|
1,772,909 | $1,790,638 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
16,500 | $1,388,805 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
28,000 | $1,376,480 | |
| 4 | BCAX |
Bicara Therapeutics Inc.
|
63,500 | $1,263,015 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,000 | $1,167,000 | |
| 6 | MANE |
Veradermics, Inc
|
18,000 | $1,136,700 | |
| 7 | QURE |
uniQure N.V.
|
67,527 | $1,104,066 | |
| 8 | VYNE |
VYNE Therapeutics Inc.
|
1,610,242 | $962,924 |
All Filings in ACHV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $603,035 | 205,114 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,167,636 | 234,937 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $912,066 | 289,545 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $661,382 | 292,647 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $709,509 | 265,734 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $88,000 | 25,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,133,000 | 450,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,115,000 | 450,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,047,500 | 450,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,987,000 | 725,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,186,300 | 741,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,030,554 | 776,600 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,264,000 | 480,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $833,000 | 340,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,122,000 | 340,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,931,303 | 395,759 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,038,355 | 401,368 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,156,478 | 405,717 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,232,465 | 380,290 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,619,613 | 403,075 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,563,300 | 135,000 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||